Compare MP & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MP | PEN |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 10.9B |
| IPO Year | N/A | 2015 |
| Metric | MP | PEN |
|---|---|---|
| Price | $61.91 | $293.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | $70.42 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 11.9M | 531.1K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | N/A | ★ 4.14 |
| Revenue | $232,742,000.00 | ★ $1,333,798,000.00 |
| Revenue This Year | $46.53 | $15.52 |
| Revenue Next Year | $149.75 | $14.20 |
| P/E Ratio | ★ N/A | $70.84 |
| Revenue Growth | ★ 26.44 | 14.61 |
| 52 Week Low | $15.56 | $221.26 |
| 52 Week High | $100.25 | $310.00 |
| Indicator | MP | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 67.32 |
| Support Level | $53.22 | $276.01 |
| Resistance Level | $59.49 | $301.22 |
| Average True Range (ATR) | 4.21 | 7.81 |
| MACD | 0.75 | 2.32 |
| Stochastic Oscillator | 65.86 | 80.80 |
MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.